215 related articles for article (PubMed ID: 21557022)
1. [Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma].
Jung EM; Uller W; Stroszczynski C; Clevert DA
Radiologe; 2011 Jun; 51(6):462-8. PubMed ID: 21557022
[TBL] [Abstract][Full Text] [Related]
2. Contrast-Enhanced Ultrasonography Versus Contrast-Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta-analysis.
Zhong J; Su Z; Zhang Y; Zhang H; Lin P; Tang X; Zheng R
J Ultrasound Med; 2018 Aug; 37(8):1881-1890. PubMed ID: 29380404
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
[TBL] [Abstract][Full Text] [Related]
4. CO2-enhanced sonographically guided radiofrequency ablation and transcatheter arterial chemoembolization for small hepatocellular carcinoma poorly defined on conventional sonography.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
J Clin Ultrasound; 2007 Feb; 35(2):78-81. PubMed ID: 17195192
[TBL] [Abstract][Full Text] [Related]
5. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation.
Lim HS; Jeong YY; Kang HK; Kim JK; Park JG
AJR Am J Roentgenol; 2006 Oct; 187(4):W341-9. PubMed ID: 16985104
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation.
Ippolito D; Trattenero C; Talei Franzesi C; Casiraghi A; Lombardi S; Vacirca F; Corso R; Sironi S
J Comput Assist Tomogr; 2016; 40(5):692-700. PubMed ID: 27560010
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency Ablation Guided by Contrast-Enhanced Sonography versus B-Mode Sonography for Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.
Kawasaki T; Hata KY; Kinoshita D; Takayama M; Okuda H; Mizuno S; Kudo M
Dig Dis; 2016; 34(6):692-695. PubMed ID: 27750239
[TBL] [Abstract][Full Text] [Related]
8. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography.
Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
[TBL] [Abstract][Full Text] [Related]
10. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation.
Lee MW; Kim YJ; Park SW; Hwang JH; Jung SI; Jeon HJ; Kwon WK
Br J Radiol; 2009 Nov; 82(983):908-15. PubMed ID: 19433482
[TBL] [Abstract][Full Text] [Related]
12. Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone.
Smolock AR; Cristescu MM; Hinshaw A; Woo KM; Wells SA; Ziemlewicz TJ; Lubner MG; Dalvie PS; Louis Hinshaw J; Brace CL; Ozkan OS; Lee FT; Laeseke P
Abdom Radiol (NY); 2018 Sep; 43(9):2497-2504. PubMed ID: 29450606
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
[TBL] [Abstract][Full Text] [Related]
14. Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases.
Dou JP; Yu J; Han ZY; Liu FY; Cheng ZG; Liang P
Abdom Radiol (NY); 2017 Mar; 42(3):962-968. PubMed ID: 27688061
[TBL] [Abstract][Full Text] [Related]
15. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
[TBL] [Abstract][Full Text] [Related]
16. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
Kim JH; Kim PN; Won HJ; Shin YM
AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
[TBL] [Abstract][Full Text] [Related]
17. Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
J Vasc Interv Radiol; 2006 Apr; 17(4):723-6. PubMed ID: 16614157
[TBL] [Abstract][Full Text] [Related]
18. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
19. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA
Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging.
Youk JH; Lee JM; Kim CS
J Ultrasound Med; 2003 Sep; 22(9):911-20. PubMed ID: 14510262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
